Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Other Operating Expenses (2017 - 2025)

Historic Other Operating Expenses for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $8.6 million.

  • Selectis Health's Other Operating Expenses rose 246.91% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.3 million, marking a year-over-year increase of 147.03%. This contributed to the annual value of $33.0 million for FY2024, which is 333.51% down from last year.
  • As of Q3 2025, Selectis Health's Other Operating Expenses stood at $8.6 million, which was up 246.91% from $8.3 million recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Other Operating Expenses registered a high of $9.7 million during Q4 2021, and its lowest value of $2.2 million during Q1 2021.
  • Its 5-year average for Other Operating Expenses is $7.6 million, with a median of $8.0 million in 2023.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 271788.09% in 2021, then crashed by 1489.77% in 2024.
  • Over the past 5 years, Selectis Health's Other Operating Expenses (Quarter) stood at $9.7 million in 2021, then dropped by 4.95% to $9.2 million in 2022, then rose by 0.66% to $9.3 million in 2023, then dropped by 11.6% to $8.2 million in 2024, then increased by 4.83% to $8.6 million in 2025.
  • Its Other Operating Expenses was $8.6 million in Q3 2025, compared to $8.3 million in Q2 2025 and $8.2 million in Q1 2025.